Systemic Pathology US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Systemic Pathology. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Systemic Pathology US Medical PG Question 1: A 78-year-old man dies suddenly from complications of acute kidney failure. An autopsy is performed and microscopic evaluation of the kidneys shows pale, swollen cells in the proximal convoluted tubules. Microscopic evaluation of the liver shows similar findings. Which of the following is the most likely underlying mechanism of these findings?
- A. Double-stranded DNA breakage
- B. Impaired Na+/K+-ATPase pump activity (Correct Answer)
- C. Free radical formation
- D. Cytochrome C release
- E. Cytoplasmic triglyceride accumulation
Systemic Pathology Explanation: ***Impaired Na+/K+-ATPase pump activity***
- **Acute kidney failure** leads to **hypoxia** and ATP depletion, which impairs the function of the **Na+/K+-ATPase pump** on the cell membrane.
- Failure of this pump results in **intracellular accumulation of sodium** and water, causing **cellular swelling** and pallor as seen in the kidneys and liver.
*Double-stranded DNA breakage*
- This is primarily associated with **apoptosis** or **radiation injury**, which would lead to nuclear fragmentation and cellular death rather than simple cellular swelling.
- While cell death can occur in acute kidney failure, the initial changes described (pale, swollen cells) are characteristic of **reversible cell injury** before extensive DNA damage.
*Free radical formation*
- **Free radical formation** (oxidative stress) can cause cellular injury, but it primarily leads to **lipid peroxidation of membranes** and damage to proteins and DNA, not directly to the widespread intracellular water accumulation described.
- While part of the injury cascade, it's not the most direct mechanism for the initial gross and microscopic findings of swelling.
*Cytochrome C release*
- **Cytochrome C release** from mitochondria is a critical step in the **intrinsic pathway of apoptosis**, leading to programmed cell death.
- The findings described (pale, swollen cells) are more indicative of **reversible cellular injury** or early necrosis, prior to the widespread activation of apoptosis.
*Cytoplasmic triglyceride accumulation*
- **Cytoplasmic triglyceride accumulation** (steatosis or fatty change) is often seen in conditions like **alcoholic liver disease** or **metabolic syndrome**.
- While it can be a sign of cellular injury, it does not directly explain the generalized "pale, swollen cells" observed in both the kidneys and liver following acute kidney failure, which points to water influx.
Systemic Pathology US Medical PG Question 2: A scientist in Chicago is studying a new blood test to detect Ab to EBV with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity much greater than what she had originally hoped for. She travels to China to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with EBV. The scientist tests these 1,200 patients' blood and finds that only 120 of them tested negative with her new exam. Of the patients who are known to be EBV-free, only 20 of them tested positive. Given these results, which of the following correlates with the exam's specificity?
- A. 82%
- B. 90%
- C. 84%
- D. 86%
- E. 98% (Correct Answer)
Systemic Pathology Explanation: ***98%***
- **Specificity** measures the proportion of **true negatives** among all actual negatives.
- In this case, 800 patients are known to be EBV-free (actual negatives), and 20 of them tested positive (false positives). This means 800 - 20 = 780 tested negative (true negatives). Specificity = (780 / 800) * 100% = **98%**.
*82%*
- This value represents the *original sensitivity* before the scientist’s new attempts to improve the test.
- It does not reflect the *newly calculated specificity* based on the provided data.
*90%*
- This value represents the *newly calculated sensitivity* of the test, not the specificity.
- Out of 1200 EBV-infected patients, 120 tested negative (false negatives), meaning 1080 tested positive (true positives). Sensitivity = (1080 / 1200) * 100% = 90%.
*84%*
- This percentage is not directly derived from the information given for either sensitivity or specificity after the new test results.
- It does not correspond to any of the calculated values for the new test's performance.
*86%*
- This percentage is not directly derived from the information given for either sensitivity or specificity after the new test results.
- It does not correspond to any of the calculated values for the new test's performance.
Systemic Pathology US Medical PG Question 3: A 23-year-old woman is brought to the emergency department 30 minutes after stepping on a piece of broken glass. Physical examination shows a 3-cm, ragged laceration on the plantar aspect of the left foot. The physician uses hydrogen peroxide to clean the wound. Which of the following is the most likely mechanism of action of this disinfectant?
- A. Formation of free radicals (Correct Answer)
- B. Intercalation of DNA
- C. Crosslinking of proteins
- D. Halogenation of nucleic acids
- E. Congealing of cytoplasm
Systemic Pathology Explanation: ***Formation of free radicals***
- **Hydrogen peroxide** acts as an **oxidizing agent**, generating highly reactive **oxygen-free radicals** (e.g., superoxide, hydroxyl radicals) that damage microbial cellular components.
- This **oxidative damage** disrupts proteins, lipids, and nucleic acids, leading to bacterial and viral cell death.
*Intercalation of DNA*
- This mechanism is characteristic of certain **chemotherapeutic agents** (e.g., doxorubicin, ethidium bromide) and some **antimicrobials**, which insert themselves between DNA base pairs, disrupting replication and transcription.
- Hydrogen peroxide does not typically target DNA in this manner for its disinfectant action.
*Crosslinking of proteins*
- This mechanism is characteristic of **aldehydes** like **formaldehyde** and **glutaraldehyde**, which form covalent bonds between amino groups of proteins, denaturing them and disrupting cellular function.
- While hydrogen peroxide can modify proteins, its primary disinfectant action is not through widespread protein crosslinking.
*Halogenation of nucleic acids*
- This mechanism is primarily associated with **halogens** such as **chlorine** and **iodine**, which react with nucleic acids to form halogenated compounds, thereby inactivating them.
- Hydrogen peroxide, while an oxidizer, does not lead to halogenation as its primary mode of action.
*Congealing of cytoplasm*
- This mechanism, which refers to the coagulation or solidification of cellular contents, is typical of **alcohols** (e.g., ethanol, isopropanol) and some **heavy metal salts** that denature proteins and lipids, leading to cell lysis.
- Hydrogen peroxide's action is more specific to oxidative damage rather than general cytoplasmic congealing.
Systemic Pathology US Medical PG Question 4: You conduct a medical research study to determine the screening efficacy of a novel serum marker for colon cancer. The study is divided into 2 subsets. In the first, there are 500 patients with colon cancer, of which 450 are found positive for the novel serum marker. In the second arm, there are 500 patients who do not have colon cancer, and only 10 are found positive for the novel serum marker. What is the overall sensitivity of this novel test?
- A. 450 / (450 + 10)
- B. 490 / (10 + 490)
- C. 490 / (50 + 490)
- D. 450 / (450 + 50) (Correct Answer)
- E. 490 / (450 + 490)
Systemic Pathology Explanation: ***450 / (450 + 50)***
- **Sensitivity** is defined as the proportion of actual positive cases that are correctly identified by the test.
- In this study, there are **500 patients with colon cancer** (actual positives), and **450 of them tested positive** for the marker, while **50 tested negative** (500 - 450 = 50). Therefore, sensitivity = 450 / (450 + 50) = 450/500 = 0.9 or 90%.
*450 / (450 + 10)*
- This formula represents **Positive Predictive Value (PPV)**, which is the probability that a person with a positive test result actually has the disease.
- It incorrectly uses the total number of **test positives** in the denominator (450 true positives + 10 false positives) instead of the total number of diseased individuals, which is needed for sensitivity.
*490 / (10 + 490)*
- This is actually the correct formula for **specificity**, not sensitivity.
- Specificity = TN / (FP + TN) = 490 / (10 + 490) = 490/500 = 0.98 or 98%, which measures the proportion of actual negative cases correctly identified.
- The question asks for sensitivity, not specificity.
*490 / (50 + 490)*
- This formula incorrectly mixes **true negatives (490)** with **false negatives (50)** in an attempt to calculate specificity.
- The correct specificity formula should use false positives (10), not false negatives (50), in the denominator: 490 / (10 + 490).
*490 / (450 + 490)*
- This calculation incorrectly combines **true negatives (490)** and **true positives (450)** in the denominator, which does not correspond to any standard epidemiological measure.
- Neither sensitivity nor specificity uses both true positives and true negatives in the denominator.
Systemic Pathology US Medical PG Question 5: A research team is studying the effects of a novel drug that was discovered to treat type 2 diabetes. In order to learn more about its effects, they follow patients who are currently taking the drug and determine whether there are adverse effects that exceed anticipated levels and may therefore be drug-related. They discover that the drug causes an excess of sudden cardiac death in 19 patients with renal failure out of 2 million total patients that are followed. Based on these results, an additional warning about this serious adverse effect is added to the investigator brochure for the drug. Which of the following clinical phase studies does this study most likely describe?
- A. Phase IV (Correct Answer)
- B. Phase II
- C. Phase V
- D. Phase III
- E. Phase I
Systemic Pathology Explanation: ***Phase IV***
- This study occurs **after a drug has been approved and marketed**, focusing on post-marketing surveillance for long-term safety, effectiveness, and real-world side effects in a large and diverse patient population.
- The discovery of a rare but serious adverse effect (sudden cardiac death) in a large patient population (2 million) after the drug is already in use is characteristic of a **Phase IV clinical trial**.
*Phase II*
- Phase II trials involve a **larger group of patients (hundreds)** and focus on evaluating the drug's effectiveness and further assessing safety in patients with the target condition.
- This phase is typically conducted **before widespread marketing** and would not involve 2 million patients.
*Phase V*
- There is **no widely recognized "Phase V"** in standard clinical trial terminology (Phases I-IV focus on drug development and post-marketing surveillance).
- This term is sometimes used informally to refer to **health economics and outcomes research** or implementation studies, which are not described in the scenario.
*Phase III*
- Phase III trials are large-scale studies involving **thousands of patients** to confirm effectiveness, monitor side effects, compare the drug to standard treatments, and collect information for safe use.
- While large, these trials are conducted **before regulatory approval** and marketing, and would not typically follow 2 million patients already taking the drug in the real world.
*Phase I*
- Phase I trials are the **first stage of human testing**, involving a small group of healthy volunteers (20-100) to assess safety, dosage, and pharmacokinetics.
- The primary goal is to determine if the drug is safe enough for further testing, not to identify rare adverse events in a large patient population.
More Systemic Pathology US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
